The Journal of Antibiotics banner image

Welcome to
The Journal of Antibiotics

An International Journal Devoted to Research on Bioactive Microbial Products

Announcements

  • Suertides A–C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3

    A novel aureothin diepoxide derivative from Streptomyces sp. NIIST-D31 strain

    In vitro activity and adaptation strategies of eravacycline in clinical Enterococcus faecium isolates from China

  • The October 2021 special issue of The Journal of Antibiotics “Approach toward molecular targeted therapy for cancer using microbial products” focuses on microbial secondary metabolites targeting molecules or signal transduction systems related to cancer development. We would like to thank Profs. Masaya Imoto and Manabu Kawada, the coordinators of this special issue.

  • The October 2020 special issue of The Journal of Antibiotics “Secondary Metabolites from Mushrooms” focuses on the compounds produced by mushrooms or cultured mycelia of mushrooms. We are extremely grateful to all the researchers for their diligence in contributing their work during the unprecedented time of the coronavirus pandemic. Coordinators: Profs. Timm Anke and Kazuro Shiomi.

The Journal of Antibiotics is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement